olprinone has been researched along with Hepatic Veno Occlusive Disease in 2 studies
olprinone: RN refers to HCl; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narita, M | 1 |
| Hatano, E | 1 |
| Ikai, I | 1 |
| Miyagawa-Hayashino, A | 1 |
| Yanagida, A | 1 |
| Nagata, H | 1 |
| Asechi, H | 1 |
| Taura, K | 1 |
| Uemoto, S | 1 |
| Kobayashi, T | 1 |
2 other studies available for olprinone and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Disease Models, Ani | 2009 |
A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Topics: Amrinone; Animals; Heme Oxygenase-1; Hepatectomy; Hepatic Veno-Occlusive Disease; Imidazoles; Phosph | 2010 |